Skip to main content
Equibles

TUDOR INVESTMENT CORP ET AL

Position in IMVT — Immunovant, Inc.

CIK 923093 STAMFORD, CT
Back to IMVT Full portfolio

Position in IMVT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,201,796
+$1,551,044 QoQ
Shares Held
57,145
+123.2% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#84
of 226 holders
Holding Since
Mar 2023
7 quarters on record
Voting authority Sole 50% Shared 50% None 0%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Derivatives in IMVT

reported options exposure · as of Dec 31, 2025
CallValue
$912,578
CallShares
35,900
PutValue
$587,202
PutShares
23,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $414,135,114 across 107 Biotechnology names. IMVT ranks #35 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TECH
BIO-TECHNE Corp
 943,287 $66,643,226
2 RPRX
Royalty Pharma plc
 610,736 $34,243,967
3 XENE
Xenon Pharmaceuticals Inc.
 545,387 $32,919,559
4 ABVX
Abivax S.A.
 187,335 $24,964,262
5 INSM
INSMED Inc
 195,391 $20,832,588
6 MLYS
Mineralys Therapeutics, Inc.
 738,370 $19,921,222
7 ABCL
AbCellera Biologics Inc.
 2,063,191 $16,196,049
8 QURE
uniQure N.V.
 328,889 $15,148,627

All Filings in IMVT

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,201,796 57,145
2025-12-31 $650,752 25,600
2025-12-31 $912,578 35,900
2025-12-31 $587,202 23,100
2025-09-30 $651,248 40,400
2025-09-30 $1,463,147 90,766
2024-03-31 $2,823,797 87,397
2023-12-31 $1,615,348 38,342
2023-06-30 $271,897 14,333
2023-03-31 $1,039,464 67,019